Luteolin attenuates neuronal apoptosis in the hippocampi of diabetic encephalopathy rats

Neural Regeneration Research

Volumn 8, Issue 12, 2013, Pages 1071-1080

  Ren, Guiru ^a   Kong, Jingjing ^a   Jia, Ning ^a   Shang, Xiuli ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; CASPASE 8; CYTOCHROME C; GLUTATHIONE; LUTEOLIN; MALONALDEHYDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN KINASE B; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DISEASE; CELL SURVIVAL; COGNITION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ENCEPHALOPATHY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HYPERGLYCEMIA; MALE; MORRIS WATER MAZE TEST; NERVE CELL; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WESTERN BLOTTING;

EID: 84890964631     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.12.002     Document Type: Article

References (16)

1. Ortiz A. Nephrology forum: apoptotic regulatory proteins in renal injury. Kidney Int. 2000;58(1):467-485.
2. Li ZG, Zhang W, Grunberger G, et al. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res. 2002; 946(2):221-231.
3. Zhang T, Jia W, Sun X. 3-n-Butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats. Neurol Res. 2010;32(4):390-396.
4. Iwabuchi M, Ohsumi K, Yamamoto TM, et al. Coordinated regulation of M phase exit and S phase entry by the Cdc2 activity level in the early embryonic cell cycle. Dev Biol. 2002;243(1):34-43.
5. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol. 2003;53 Suppl 3:S26-36.
6. Eckert A, Keil U, Marques CA, et al. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol. 2003;66(8): 1627-1634.
7. Mukherjee PK, Marcheselli VL, Serhan CN, et al. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A. 2004; 101(22):8491-8496.
8. Yamamoto T, Maruyama W, Kato Y, et al. Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells. J Neural Transm. 2002; 109(1):1-13.
9. Qiao H, Dong L, Zhang X, et al. Protective Effect of luteolin in experimental ischemic stroke: upregulated SOD1, CAT, Bcl-2 and Claudin-5, down-regulated MDA and Bax expression. Neurochem Res. 2012;37(9): 2014-2024.
10. Zhao G, Zang SY, Jiang ZH, et al. Postischemic administration of liposome-encapsulated luteolin prevents against ischemia-reperfusion injury in a rat middle cerebral artery occlusion model. J Nutr Biochem. 2011; 22(10):929-936.
11. He D, Ma X, Chen Y, et al. Luteolin inhibits pyrogallol-induced apoptosis through the extracellular signal-regulated kinase signaling pathway. FEBS J. 2012;279(10):1834-1843.
12. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
13. Sun D, Huang J, Zhang Z, et al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One. 2012;7(3): e33491.
14. Tuzcu M, Baydas G. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur J Pharmacol. 2006;537(1-3):106-110.
15. Colado MI, O'Shea E, Granados R, et al. Astudy of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br J Pharmacol. 1997;121(4):827-833.
16. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70-77.